Login / Signup

Cardiovascular drugs and COVID-19 clinical outcomes: A living systematic review and meta-analysis.

Innocent Gerald AsiimweSudeep PushpakomRichard M TurnerRuwanthi Kolamunnage-DonaAndrea L JorgensenMunir Pirmohamed
Published in: British journal of clinical pharmacology (2021)
Cardiovascular drugs are not associated with poor COVID-19 outcomes in adjusted analyses. Patients should continue taking these drugs as prescribed.
Keyphrases
  • coronavirus disease
  • sars cov
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • skeletal muscle
  • patient reported outcomes
  • insulin resistance